Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin is a research paper published in Aging Cell (2022). On theSindex it has a DataRank of 0.639. It has been cited 70 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.639
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: K01 AG054731
National Institutes of Health
Grant: T32 AG000279
National Institutes of Health
Grant: UL1 TR001082
NCATS NIH HHS
Grant: UL1 TR002535
National Institutes of Health
Grant: 5UL1TR001082-05
Colorado Clinical and Translational Sciences Institute
National Institutes of Health
Grant: 5K01AG054731-06
NAD+ Therapy for Improving Memory & Cerebrovasular Function in Patients with MCI
National Institutes of Health
Grant: 2T32AG000279-06A1
University of Colorado Aging Training Grant
National Institute on Aging
American Federation for Aging Research
FWCI
4.93
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model
Additional file 1 of Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model